PRO83 DATA SOURCES USED TO DETERMINE THE TARGET POPULATION SIZE FOR ORPHAN DRUGS - A REVIEW OF GERMAN AMNOG BENEFIT ASSESSMENTS
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.2413
https://www.valueinhealthjournal.com/article/S1098-3015(19)34791-6/fulltext
Section Title :
Section Order :
12111
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34791-6&doi=10.1016/j.jval.2019.09.2413